Meridian Daily News

The Ozempic Economy: Inside the $100 Billion GLP-1 Gold Rush

By Evelyn Hartwell · 6 min read

BUSINESS

The pharmacy fridge at a Walgreens in suburban Chicago is usually a quiet place.

BUSINESS

GLP-1 weight loss drugs—short for glucagon-like peptide-1—have moved from the niche world of endocrinology to the center of the global conversation.

BUSINESS

To understand why everyone is obsessed with 'the shot,' you have to understand the biology.

BUSINESS

But here’s the kicker: they were never intended to be weight-loss miracles.

BUSINESS

It was the beginning of a duopoly.

BUSINESS

If you’ve tried to fill a prescription for Zepbound or Wegovy lately, you know the frustration.

Meridian

Daily News

Read the full reporting at meridiandailynews.com

Read full story

Continue reading on Meridian Daily News